CSS
DCOY

Cubist Systematic Strategies’s Decoy Therapeutics DCOY Stock Holding History

Cubist Systematic Strategies’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-93
Closed -$15K – 3508
2025
Q2 		$15K Buy
+93
New +$13.1K ﹤0.01% 2832

Other funds holding DCOY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Cubist Systematic Strategies's DCOY Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Decoy Therapeutics (DCOY) in Q3 2025, closing a stake of 93 shares — an estimated $15K sold.

Cubist Systematic Strategies first reported a position in DCOY in Q2 2025 and held it in 1 quarter. The position peaked at $15K in Q2 2025. 3 funds tracked by Wall St. Rank hold DCOY as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Decoy Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 93 Decoy Therapeutics shares in Q3 2025, an estimated $15K.
  • Cubist Systematic Strategies first reported a position in Decoy Therapeutics in Q2 2025 and held it in 1 quarter.
  • Cubist Systematic Strategies's Decoy Therapeutics position peaked at $15K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.